Sleep apnea: the diagnosis hiding in plain sight for men over 35

Obstructive sleep apnea is a condition where the airway repeatedly collapses during sleep, causing brief pauses in breathing that the brain interprets as suffocation. Each pause triggers a small adrenal response: heart rate spikes, blood pressure jumps, and the brain partially wakes up to restore the airway. In moderate-to-severe apnea, this can happen 30, 60, or even 100 times per hour.

The cumulative effect is not just bad sleep. Each cycle of oxygen drop and adrenaline release damages the cardiovascular system over time. Untreated moderate-to-severe apnea is associated with hypertension that does not respond well to medication, atrial fibrillation, increased stroke risk, accelerated coronary artery disease, and insulin resistance. People with untreated severe apnea have shorter average lifespans by a clinically meaningful margin.

The frustrating part is that the disease is treatable, often dramatically so. Patients who treat their apnea consistently see blood pressure drop, energy return, mood stabilize, and cognitive performance improve, sometimes within weeks. The bottleneck is diagnosis, not treatment.

The CDC and major sleep medicine societies estimate that around 30 million American adults have obstructive sleep apnea. Studies that screen broad populations consistently find that 70-80% of those people are undiagnosed. The undertreated rate is even higher.

Part of the problem is symptom overlap with normal life. Most people do not feel rested. Most middle-aged men snore. Most working adults are tired in the afternoon. The signs that should trigger an apnea workup get blurred into the general background noise of being a busy 45-year-old.

Another part is the typical patient profile. The classic image of an apnea patient is older, overweight, and male, but apnea is common across body types. Lean men with narrow airways, men with deviated septa, and men with thick necks all have higher rates than the general population. Body weight is the single largest modifiable risk factor, but it is not the whole story.

The third part is that the most reliable witness, a partner, often does not connect what they observe to a medical condition. Snoring loud enough to be heard from another room, pauses in breathing followed by a gasp or snort, restless tossing through the night, are classic apnea signs. People often assume those things are funny stories rather than symptoms.

The signs to watch for fall into two groups: nighttime symptoms that someone else can usually observe, and daytime symptoms that only you experience.

Nighttime: loud, regular snoring; pauses in breathing followed by a gasp, snort, or choking sound; restless sleep with frequent position changes; needing to urinate two or more times per night; waking with a dry mouth or sore throat; waking with a headache.

Daytime: persistent fatigue that coffee does not fix; falling asleep during quiet activities like reading or watching TV; difficulty concentrating; irritability that has gotten worse over time; reduced libido; brain fog that comes and goes.

A simple screening tool used in clinics is the STOP-BANG questionnaire, which scores eight risk factors: snoring, tiredness, observed apnea, blood pressure, BMI over 35, age over 50, neck circumference over 17 inches, and male sex. A score of 3 or more is enough to warrant a sleep study. Most middle-aged men score 3 or higher just from the demographic factors alone, which is why the threshold to test should be low.

There are two main types of sleep studies. An in-lab polysomnography is the traditional version: you spend a night at a sleep center while a technician records dozens of physiological signals including brainwaves, eye movements, heart rhythm, oxygen, breathing patterns, and limb movements. It is the most thorough test and the standard for complicated cases.

Home sleep apnea testing is a simpler version that you do in your own bed with a small recorder, a pulse oximeter, and a couple of breathing sensors. It does not capture brainwaves, so it is not appropriate for diagnosing other sleep disorders, but it is highly accurate for moderate-to-severe obstructive sleep apnea in patients without major comorbidities. For most uncomplicated cases, a home study is now the first-line test.

The result is usually expressed as an apnea-hypopnea index (AHI), which is the average number of apnea or partial-airway events per hour of sleep. An AHI of 5-15 is mild apnea, 15-30 is moderate, and over 30 is severe. The decision to treat depends on AHI, your symptoms, and your cardiovascular risk profile.

CPAP, or continuous positive airway pressure, is still the most effective treatment for moderate-to-severe apnea. A small machine pushes a steady stream of pressurized air through a mask, which keeps the airway open during sleep. When it works, it works dramatically: full normalization of nighttime breathing, often on the first night.

Modern CPAP machines are quieter, smaller, and smarter than the equipment from 15 years ago. Auto-adjusting pressure, heated humidification, and a wide range of mask designs (full-face, nasal, nasal pillow) have made the experience more tolerable. Adherence is still the main challenge: about half of patients prescribed CPAP are still using it consistently a year later, and the failure mode is usually mask discomfort or claustrophobia rather than the device itself. A second mask trial after a bad first experience is a common and underused step.

Oral appliances are custom-fitted dental devices that hold the lower jaw slightly forward during sleep, opening the airway. They are appropriate for mild-to-moderate apnea and for patients who cannot tolerate CPAP. Effectiveness is real but more variable than CPAP, and they need to be fitted by a dentist trained in sleep medicine.

Positional therapy, weight loss, and avoiding alcohol within a few hours of bed all reduce apnea severity and are worth doing alongside whatever device you use. For some patients, side-sleeping alone reduces apnea events by half or more. Newer surgical options like hypoglossal nerve stimulators (Inspire) are an option for selected patients who fail CPAP, though candidacy criteria are strict.

Body weight is the single largest modifiable factor in obstructive sleep apnea. Adipose tissue around the neck and tongue narrows the airway and makes collapse more likely. Even modest weight loss, on the order of 10% of body weight, can move someone from moderate apnea into mild or resolve it entirely. The recent boom in GLP-1 weight loss has produced a wave of patients whose apnea improved or remitted as they lost weight.

Alcohol relaxes the muscles of the upper airway, makes apnea worse, and disrupts sleep architecture even at modest amounts. The general rule for men with apnea is that drinks within 3-4 hours of bed measurably worsen the night. Cutting evening drinking is one of the highest-leverage changes a man with apnea can make.

Sleep position matters more than people expect. About 60% of apnea patients have what is called positional apnea, meaning the disease is significantly worse when sleeping on the back. A simple device, even a tennis ball sewn into the back of a sleep shirt or a positional belt, can reduce events meaningfully.

Sleep timing matters too. Going to bed and waking at consistent times, getting daylight in the morning, and limiting evening screen exposure all support the underlying systems that make sleep restorative. None of these replace treatment for diagnosed apnea, but they meaningfully amplify it.

For patients who use CPAP consistently, the first month often produces results that surprise them. Daytime energy returns. Morning headaches stop. Blood pressure begins to drop. Cognitive sharpness improves. Libido often comes back. Many patients describe the first week of consistent CPAP as the best sleep they have had in a decade.

The harder cases are patients who have lived with severe apnea long enough that they no longer remember what rested feels like. The recalibration takes longer for them, sometimes 4-8 weeks, before the difference becomes obvious. Stick with it. The people who quit at week two are the people who do not get the benefit.

There is also a safety dimension that often goes unmentioned. Untreated moderate-to-severe apnea raises the risk of motor vehicle accidents to a degree that is comparable to driving while moderately impaired. Patients who treat their apnea consistently see that risk drop back to baseline within weeks. For commercial drivers and patients with long commutes, this alone is reason enough to pursue treatment.

If the diagnosis fits and you have not pursued testing, the simplest next step is a home sleep study, which can usually be ordered through a primary care provider or a sleep medicine clinic. The barrier to testing has dropped substantially in the last five years and the upside of catching apnea is too high to leave on the table.